Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

CureVac reports promising preclinical data for its second-generation COVID-19 vaccine candidate

May 17, 2021

New hepatitis C virus NS5A protein inhibitors discovered at Alla Chem

May 14, 2021

Preclinical characterization of novel 3CL(pro) inhibitors against COVID-19

May 13, 2021

Mabwell initiates first-in-human study of 9MW-1411

May 13, 2021

Inovio reports preclinical data on next-generation pan-COVID-19 vaccine candidate INO-4802

May 13, 2021

New anti-HBV compounds identified at Sunshine Lake Pharma

May 13, 2021

ReViral synthesizes new benzodiazepine derivatives

May 13, 2021

NVX-CoV2373 vaccine shows efficacy against the B.1.351 variant of COVID-19

May 12, 2021

Takeda reports interim Japanese phase I/II data on Moderna's mRNA COVID-19 vaccine candidate

May 12, 2021

Novartis patents new antimalarials

May 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...